Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
Pump it Georgie! | crescentmotor | investorshub | 10/03/2023 3:42:39 AM |
Tens of millions of people have been prevented | crescentmotor | investorshub | 10/03/2023 3:39:40 AM |
Expect an Anavex 2-73, blarcamesine peer reviewed paper | georgejjl | investorshub | 10/03/2023 3:13:17 AM |
I heard there are actually people in this | Reyeton | investorshub | 10/03/2023 3:06:06 AM |
Let us know once you get hold of | Investor2014 | investorshub | 10/03/2023 2:39:54 AM |
13,338,833,198 COVID vaccinations have been administered. | georgejjl | investorshub | 10/03/2023 2:39:53 AM |
COMPLETE NONSENSE!!! | georgejjl | investorshub | 10/03/2023 2:31:27 AM |
2,524,484 REPORTS OF VACCINE ADVERSE EVENTS IN VAERS | Reyeton | investorshub | 10/03/2023 2:22:36 AM |
A simple way to calculate threshold for p-value | PeterKarol | investorshub | 10/03/2023 1:35:40 AM |
Almost Half of All New Drug Approvals in | RedShoulder | investorshub | 10/03/2023 12:43:40 AM |
COMPLETE NONSENSE!!! | georgejjl | investorshub | 10/03/2023 12:43:10 AM |
Katalin Karik and Drew Weissman have been awarded | crescentmotor | investorshub | 10/03/2023 12:23:35 AM |
Best post of the day, and most informative IMO. | RedShoulder | investorshub | 10/02/2023 11:55:50 PM |
Jonjones-This waiting sucks--well said---been 10 months since we | plexrec | investorshub | 10/02/2023 11:22:22 PM |
That's funny.😎 | Steady_T | investorshub | 10/02/2023 10:51:59 PM |
On whom? | Joseph_K | investorshub | 10/02/2023 10:04:01 PM |
Katalin Karik and Drew Weissman have been awarded | georgejjl | investorshub | 10/02/2023 9:25:08 PM |
Nope, I have them all on ignore | D-Mike | investorshub | 10/02/2023 9:19:29 PM |
Yep, thats right when Fartstain hit the air | D-Mike | investorshub | 10/02/2023 9:18:21 PM |
You're not mad at the waiting you are | WolfofMia | investorshub | 10/02/2023 9:01:23 PM |
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceu...
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...